Valuing mortality risk reductions in global benefit-cost analysis
LA Robinson, JK Hammitt, L O'Keeffe - Journal of Benefit-Cost …, 2019 - cambridge.org
The estimates used to value mortality risk reductions are a major determinant of the benefits
of many public health and environmental policies. These estimates (typically expressed as …
of many public health and environmental policies. These estimates (typically expressed as …
Policy brief—What's in a name? A search for alternatives to “VSL”
Benefit–cost analyses of environmental, health, and safety regulations often rely on an
estimate of the value of statistical life (VSL) to calculate the aggregate benefits of reducing …
estimate of the value of statistical life (VSL) to calculate the aggregate benefits of reducing …
[PDF][PDF] Health and air pollution in New Zealand 2016 (HAPINZ 3.0)
NZ Waka Kotahi - 2022 - nzta.govt.nz
Research Report 696 HAPINZ 3.0 Volume 2: Detailed methodology Page 1 Suite 2-3, 93
Dominion Rd Mt Eden, Auckland 1024 www.emissionimpossible.co.nz and the HAPINZ 3.0 …
Dominion Rd Mt Eden, Auckland 1024 www.emissionimpossible.co.nz and the HAPINZ 3.0 …
[PDF][PDF] A Generalized Framework for CBA of Asbestos Bans with Case Study in Colombia
C Gerbode, G Sun, A Wang, X Wang - 2019 - dukespace.lib.duke.edu
Conclusions Colombia may ban asbestos in the coming years, based on recent legislative,
judicial, and civil society developments. Our model suggests a ban would have a positive …
judicial, and civil society developments. Our model suggests a ban would have a positive …